NCT03995316

Brief Summary

Perinatal depression is experienced by at least 14-20% of pregnant and postpartum women, and is recognized as the most common complication of childbirth. In this project, the investigators plan to complete the process of making MomMoodBooster (MMB), a web-based cognitive-behavioral depression intervention, into a commercial ready product, MMB 2.0, that fits the workflow and staffing of healthcare organizations and is designed for both prenatal and postpartum women who are depressed. The investigators will also conduct a 2-arm randomized controlled trial to evaluate the efficacy of treatment as usual plus MMB 2.0 compared to treatment as usual in a large healthcare setting.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
191

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2018

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 24, 2018

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 17, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 24, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2021

Completed
2.2 years until next milestone

Results Posted

Study results publicly available

October 12, 2023

Completed
Last Updated

October 12, 2023

Status Verified

October 1, 2023

Enrollment Period

2.8 years

First QC Date

June 17, 2019

Results QC Date

August 23, 2023

Last Update Submit

October 10, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Primary Health Questionnaire (PHQ-9)

    The PHQ-9 measures self-reports of depressive symptoms within the prior 2 weeks and has been well-validated, shown high test-retest reliability, shown high internal consistency, and shown to be responsive to changes in treatment. Response options are on a 4-point scale (0 = not at all, 3 = nearly every day). The minimum overall score is 0 and the maximum overall score for the PHQ-9 is 27. Higher values represent more severe depression status.

    Pretest (at enrollment) and posttest (3 months post enrollment)

Secondary Outcomes (5)

  • Change in General Anxiety Disorder (GAD)

    Pretest (at enrollment) and posttest (3 months post enrollment)

  • Change in Stress

    Pretest (at enrollment) and posttest (3 months post enrollment)

  • Change in Behavioral Activation for Depression Scale (BADS)

    Pretest (at enrollment) and posttest (3 months post enrollment)

  • Change in Automatic Thoughts Questionnaire - Short Form (ATQ)

    Pretest (at enrollment) and posttest (3 months post enrollment)

  • Change in Self-Efficacy

    Pretest (at enrollment) and posttest (3 months post enrollment)

Study Arms (2)

Treatment As Usual + MMB 2.0

OTHER

Women assigned to use MMB 2.0, along with NorthShore HealthSystem's well established usual care, will be guided by the program to move sequentially through 6 sessions, one of which becomes available for use each week, while interacting with engaging activities within each session along with recommended practice activities to encourage transfer of learning and skills to everyday routines. Content is presented using text, interactions, animations, and videos. MMB includes daily tracking and charting of mood and pleasant activities as well as online access to a library, covering a range of issues of concern to pregnant women and new mothers. Integrated text messages offer both motivational messages and links to access specific portions of session content in the MMB 2.0 program. The study coordinator will also provide up to 3 supportive coaching calls to each woman in the MMB 2.0 condition. These calls complement and thus are adjunctive to the MMB 2.0 program.

Behavioral: Treatment As Usual + MMB 2.0

Treatment As Usual Only

OTHER

NorthShore HealthSystem's treatment as usual, or usual care, has been in place since 2003. Screen positive women randomized to this condition will receive social work assessment by phone, followed by community mental health referral as indicated. Referrals will vary by need and may include psychotherapy, support groups, or psychiatry. Referrals will include consideration of geographic proximity, insurance, and acuity. Consistent with routine practice, NorthShore staff will document time spent during evaluation and in making specific referrals.

Behavioral: Treatment As Usual Only

Interventions

Women assigned to use MMB 2.0, along with NorthShore HealthSystem's well established usual care, will be guided by the program to move sequentially through 6 sessions, one of which becomes available for use each week, while interacting with engaging activities within each session along with recommended practice activities to encourage transfer of learning and skills to everyday routines. Content is presented using text, interactions, animations, and videos. MMB includes daily tracking and charting of mood and pleasant activities as well as online access to a library, covering a range of issues of concern to pregnant women and new mothers. Integrated text messages offer both motivational messages and links to access specific portions of session content in the MMB 2.0 program. The study coordinator will also provide up to 3 supportive coaching calls to each woman in the MMB 2.0 condition. These calls complement and thus are adjunctive to the MMB 2.0 program.

Treatment As Usual + MMB 2.0

NorthShore HealthSystem's treatment as usual, or usual care, has been in place since 2003. Screen positive women randomized to this condition will receive social work assessment by phone, followed by community mental health referral as indicated. Referrals will vary by need and may include psychotherapy, support groups, or psychiatry. Referrals will include consideration of geographic proximity, insurance, and acuity. Consistent with routine practice, NorthShore staff will document time spent during evaluation and in making specific referrals.

Treatment As Usual Only

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • pregnant or postpartum
  • have elevated Edinburgh Postnatal Depression Scale (EPDS) of ≥ 12
  • access to broadband internet and a computer at home (desktop, laptop, tablet) or a smartphone (iOS or Android)
  • English language proficiency sufficient to enable completion of the informed consent and to engage in all study activities that are delivered in English

You may not qualify if:

  • Women assessed with active suicidal ideation will be excluded and provided with immediate psychiatric care consistent with NorthShore's established safety protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

NorthShore University HealthSystem

Chicago, Illinois, 60201, United States

Location

Oregon Research Behavioral Intervention Strategies, Inc.

Springfield, Oregon, 97477, United States

Location

Related Publications (1)

  • Danaher BG, Seeley JR, Silver RK, Tyler MS, Kim JJ, La Porte LM, Cleveland E, Smith DR, Milgrom J, Gau JM. Trial of a patient-directed eHealth program to ameliorate perinatal depression: the MomMoodBooster2 practical effectiveness study. Am J Obstet Gynecol. 2023 Apr;228(4):453.e1-453.e10. doi: 10.1016/j.ajog.2022.09.027. Epub 2022 Sep 26.

MeSH Terms

Interventions

Therapeutics

Results Point of Contact

Title
David Smith
Organization
Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 2-Arm random control trial
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 17, 2019

First Posted

June 24, 2019

Study Start

August 24, 2018

Primary Completion

May 31, 2021

Study Completion

July 31, 2021

Last Updated

October 12, 2023

Results First Posted

October 12, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations